|
Bal
Pharma chalks out plans to become Rs 300-crore company
City-based Bal Pharma having a strong presence in antibiotics and
gynaecology drugs segment, has chalked out an aggressive growth
plan for the coming years. The companys aim is to become a
Rs 300 crore entity in a matter of five years, and one among the
top 50 as soon as possible.
Ideal
Cures sets up three application labs abroad
Mumbai-based Ideal Cures Pvt Ltd, a leading developer, manufacturer
and supplier of film coating systems and other specialty products,
has set up three new application laboratories in Germany, UK and
Bangladesh.
|